FRANKFURT, Oct 31 (Reuters) - Sanofi-Aventis (SASY.PA) wants to double its vaccine business in the next five years, its chief executive told a German newspaper on Saturday.
“We want to double it in the next five years. Its share in group sales will increase as a result from 10-11 percent to 15-16 percent,” Chris Viehbacher told Frankfurter Allgemeine Zeitung.
He said this was one of the reasons Sanofi-Aventis had bought a company in India, which has new vaccines, such as against cholera, in the pipeline.
There is also an enormous potential in Asia, he added.